| Date | Time | Source | Announcement |
|---|---|---|---|
| 18 Jan 2021 | 02:06 PM | Second Price Monitoring Extn | |
| 18 Jan 2021 | 02:00 PM | Price Monitoring Extension | |
| 18 Jan 2021 | 11:05 AM | Second Price Monitoring Extn | |
| 18 Jan 2021 | 11:01 AM | Price Monitoring Extension | |
| 15 Jan 2021 | 04:40 PM | Second Price Monitoring Extn | |
| 15 Jan 2021 | 04:35 PM | Price Monitoring Extension | |
| 11 Jan 2021 | 07:00 AM | Additional patent licence with Mount Sinai | |
| 23 Dec 2020 | 07:00 AM | Appointment of Senior Director | |
| 12 Nov 2020 | 04:34 PM | Holding(s) in Company | |
| 12 Nov 2020 | 04:34 PM | Holding(s) in Company | |
| 05 Nov 2020 | 05:03 PM | Holding(s) in Company | |
| 03 Nov 2020 | 07:00 AM | AIM Admission & First Day of Dealings |
Verici Dx is an immuno-diagnostics company that produces advanced clinical tests and organ transplant platforms for kidney transplant patients.
Verici Dx share price is listed in London under the ticker VRCI.